4Front Ventures Corp. (CSE:FFNT)

Market Cap	4.58M
Revenue (ttm)	102.14M
Net Income (ttm)	-49.18M
Shares Out	916.38M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,133
Average Volume	110,675
Open	0.0050
Previous Close	0.0050
Day's Range	0.0050 - 0.0050
52-Week Range	0.0050 - 0.2000
Beta	0.95
RSI	39.98
Earnings Date	Apr 7, 2026

About 4Front Ventures

4Front Ventures Corp. engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States. The company operates through three segments: Illinois, Massachusetts, and Corporate. It offers flower, pre-rolls, vaporizers, concentrates, edibles, tinctures and soft gels, capsules, and topicals, as well as provides a vertically integrated supply chain to serve both medical and recreational markets. The company owns, operates, and manages cultivation and manufacturing facilities and retail centers; sales CBD products to...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2011
• Employees: 399
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: FFNT

Financial Performance

In 2023, 4Front Ventures's revenue was $97.44 million, a decrease of -9.50% compared to the previous year's $107.66 million. Losses were -$91.65 million, 95.4% more than in 2022.

Financial numbers in USD